Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine.
Ponticelli C, Yussim A, Cambi V, Legendre C, Rizzo G, Salvadori M, Kahn D, Kashi SH, Salmela K, Fricke L, Garcia-Martinez J, Lechler R, Heemann U, Monteon F, Ortuño J, Amenabar JJ, Arias M, Nicholson ML, Sperschneider H, Abendroth D, Gracida C, Lao M, Sever MS, Lameire N, Sanchez-Fructuoso A, Bascì A, Segoloni G, Connolly J, Altieri P, Akoh J, Prestele H, Girault D.
Ponticelli C, et al. Among authors: heemann u.
Transplant Proc. 2001 Feb-Mar;33(1-2):1009-10. doi: 10.1016/s0041-1345(00)02307-1.
Transplant Proc. 2001.
PMID: 11267167
Clinical Trial.
No abstract available.